Does ROFLUMILAST Cause Product distribution issue? 5 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Product distribution issue have been filed in association with ROFLUMILAST (ROFLUMILAST). This represents 0.2% of all adverse event reports for ROFLUMILAST.
5
Reports of Product distribution issue with ROFLUMILAST
0.2%
of all ROFLUMILAST reports
1
Deaths
1
Hospitalizations
How Dangerous Is Product distribution issue From ROFLUMILAST?
Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.
Is Product distribution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROFLUMILAST. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ROFLUMILAST Cause?
Death (569)
Dyspnoea (433)
Chronic obstructive pulmonary disease (292)
Diarrhoea (265)
Off label use (242)
Weight decreased (224)
Nausea (191)
Pneumonia (176)
Headache (166)
Malaise (164)
What Other Drugs Cause Product distribution issue?
LENALIDOMIDE (858)
CERTOLIZUMAB PEGOL (403)
SECUKINUMAB (340)
RUXOLITINIB (301)
HUMAN IMMUNOGLOBULIN G (279)
POMALIDOMIDE (254)
RELUGOLIX (243)
VEDOLIZUMAB (150)
PIMAVANSERIN (134)
TEDUGLUTIDE (132)
Which ROFLUMILAST Alternatives Have Lower Product distribution issue Risk?
ROFLUMILAST vs ROLAPITANT
ROFLUMILAST vs ROMIDEPSIN
ROFLUMILAST vs ROMIPLOSTIM
ROFLUMILAST vs ROMOSOZUMAB
ROFLUMILAST vs ROMOSOZUMAB-AQQG